Gail E Reiner
Overview
Explore the profile of Gail E Reiner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
202
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sharpe C, Yang D, Haas R, Reiner G, Lee L, Capparelli E
Arch Dis Child
. 2024 Jun;
109(10):854-860.
PMID: 38902005
Objectives: To confirm that levetiracetam (LEV) demonstrates predictable pharmacokinetics(PK) at higher doses and to study the pharmacodynamics(PD) of LEV. Design: Pharmacokinetic data from the NEOLEV1 and NEOLEV2 trials were analysed...
2.
Sharpe C, Reiner G, Davis S, Nespeca M, Gold J, Rasmussen M, et al.
Pediatrics
. 2020 May;
145(6).
PMID: 32385134
Background And Objectives: There are no US Food and Drug Administration-approved therapies for neonatal seizures. Phenobarbital and phenytoin frequently fail to control seizures. There are concerns about the safety of...
3.
Sharpe C, Davis S, Reiner G, Lee L, Gold J, Nespeca M, et al.
J Clin Neurophysiol
. 2018 Oct;
36(1):9-13.
PMID: 30289769
Purpose: Continuous video electroencephalography (cEEG) monitoring is the recommended gold standard of care for at-risk neonates but is not available in many Neonatal Intensive Care Units (NICUs). To conduct a...
4.
Naviaux R, Curtis B, Li K, Naviaux J, Bright A, Reiner G, et al.
Ann Clin Transl Neurol
. 2017 Jul;
4(7):491-505.
PMID: 28695149
Objective: No drug is yet approved to treat the core symptoms of autism spectrum disorder (ASD). Low-dose suramin was effective in the maternal immune activation and Fragile X mouse models...
5.
Brandler W, Antaki D, Gujral M, Noor A, Rosanio G, Chapman T, et al.
Am J Hum Genet
. 2016 Mar;
98(4):667-79.
PMID: 27018473
Genetic studies of autism spectrum disorder (ASD) have established that de novo duplications and deletions contribute to risk. However, ascertainment of structural variants (SVs) has been restricted by the coarse...
6.
Golomb B, Erickson L, Scott-Van Zeeland A, Koperski S, Haas R, Wallace D, et al.
J Child Neurol
. 2013 Oct;
29(2):187-93.
PMID: 24141271
We sought to examine, via Phosphorus-31 magnetic resonance spectroscopy ((31)P-MRS) in a case-control design, whether bioenergetic deficits in autism spectrum disorders extend to the brain and muscle. Six cases with...
7.
Smith M, Flodman P, Gargus J, Simon M, Verrell K, Haas R, et al.
Biochim Biophys Acta
. 2012 Apr;
1817(10):1796-802.
PMID: 22538295
To evaluate the potential importance in autistic subjects of copy number variants (CNVs) that alter genes of relevance to bioenergetics, ionic metabolism, and synaptic function, we conducted a detailed microarray...